Scworx Corp

Scworx Corp(WORX)股票分析

$12.720

-3.908 (-30.72%)收盤時

Loading chart…
High
18.360
Open
17.220
VWAP
14.44
Vol
145.45K
Mkt Cap
2.08M
Low
12.240
Amount
2.10M
EV/EBITDA, TTM
0.00

SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing.

AI analysis of Scworx Corp (WORX)

hold

Scworx Corp (WORX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, there are no significant trading trends, and the financial performance shows improvement in revenue and gross margin but remains negative in net income and EPS. Additionally, there are no positive news catalysts or strong trading signals to support an immediate buy decision.

估值指標

The current forward P/E ratio for Scworx Corp (WORX) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
高估
0.00
低估
0.00

Alphio AI Price Scenarios for WORX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%WORX

$0.50

情境價格

B

Base

Base · 50%WORX

$0.50

情境價格

B

Bear

Bear · 25%WORX

$0.42

情境價格

事件時間軸

2026-08-06 (ET)

11:30:00

SCWorx Signs Two-Year Agreement with Major Massachusetts Healthcare Network

2026-06-30 (ET)

11:00:00

SCWorx Secures Data Management Agreement with Non-Profit Hospital

2026-06-23 (ET)

16:00:00

SCWorx Receives Nasdaq Approval to Continue Listing

2026-04-09 (ET)

20:00:00

Scworx Corp Trading Halted, News Pending

2026-03-04 (ET)

10:20:00

SCWorx Signs New Customer Agreement with Southeastern Healthcare Provider

資訊

WORX FAQ — answered by Alphio AI

SCWorx Corp. is a provider of data content and services related to the repair, normalization and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. The Company has developed and markets health care information technology solutions and associated services that enhance healthcare processes and information flow within hospitals and other healthcare facilities. Its software enables a healthcare provider to simplify and organize its data (data normalization), allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics (big data). Its software modules include virtualized item master file repair, expansion and automation, electronic medical record management, charge description master management, contract management, request for proposal (RFP) automation, integration of acquired businesses, rebate management, and data integration and warehousing. It operates in the Industrials sector (SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION industry).

Scworx Corp (WORX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, there are no significant trading trends, and the financial performance shows improvement in revenue and gross margin but remains negative in net income and EPS. Additionally, there are no positive news catalysts or strong trading signals to support an immediate buy decision.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始